study of immunotherapy combinations for patients with her2-positive metastatic breast cancer
Published 5 years ago • 1.6K plays • Length 4:27Download video MP4
Download video MP3
Similar videos
-
49:09
metastatic breast cancer forum 2018: her2-positive breast cancer | dana-farber cancer institute
-
4:31
study of atezolizumab with pertuzumab and trastuzumab in her2- positive metastatic breast cancer
-
5:21
study of neratinib for patients with her2-positive breast cancer with brain metastases
-
33:41
clinical trials for metastatic breast cancer: what you should know | dana-farber cancer institute
-
23:52
breast cancer and the immune system at mbc patient forum 2019
-
28:49
dana-farber facebook live chat: immunotherapy and breast cancer
-
3:19
study of targeted therapy for her2-positive metastatic breast cancer
-
8:25
study of nab-paclitaxel with pembrolizumab for patients with hr /her2- breast cancer
-
33:26
breast cancer breakout: rapid research developments and new treatment combinations
-
6:29
study of palbociclib after cdk & endocrine therapy in er /her2- metastatic breast cancer
-
53:19
her2 positive breast cancer: what's new in treatment and research at mbc patient forum 2019
-
26:31
targeting advanced triple-negative breast cancer | dana-farber cancer institute
-
17:33
metastatic breast cancer forum, latest research part 1| dana-farber cancer institute
-
4:14
study of gdc-0084 with trastuzumab in her2-positive breast cancer with brain metastases
-
0:59
treatment for early stage her2 breast cancer | dana-farber cancer institute
-
4:59
study of saci-io for hormone receptor positive metastatic breast cancer
-
17:01
breast cancer genomics and precision cancer medicine | dana-farber cancer institute
-
1:08
a study investigating pembrolizumab in combination with eribulin in tnbc
-
2:33
breast cancer: young mother embraces life | dana-farber cancer institute